Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 5/20 | 0.46 |
| ▸ | CTSK | P43235 | 5/20 | 0.46 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | CTSH | P09668 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12468722 | 1.00 | SIGMAR1 (0.56) | SIGMAR1ACEMEN1KMT2ATAAR1 | |
| SCHEMBL21654011 | 0.84 | CAPN1 (0.49) | SIGMAR1ACEMEN1KMT2ATAAR1 | |
| SCHEMBL24288430 | 0.83 | SIGMAR1 (0.53) | SIGMAR1ACEMEN1KMT2ATAAR1 | |
| SCHEMBL5028604 | 0.83 | SIGMAR1 (0.53) | SIGMAR1ACEMEN1KMT2ATAAR1 | |
| SCHEMBL9726218 | 0.82 | SIGMAR1 (0.50) | SIGMAR1CTSBCTSKCTSLCTSH | |
| SCHEMBL16944013 | 0.81 | ACE (0.49) | ACEMEN1KMT2ATAAR1EPHX1 | |
| SCHEMBL18494852 | 0.81 | ACE (0.49) | ACEMEN1KMT2ATAAR1EPHX1 | |
| SCHEMBL13259262 | 0.81 | ACE (0.50) | ACECAPN1CTSBCTSKCTSL | |
| SCHEMBL2920753 | 0.81 | TAAR1 (0.53) | SIGMAR1ACEMEN1KMT2ATAAR1 | |
| SCHEMBL6852338 | 0.81 | TAAR1 (0.53) | SIGMAR1ACEMEN1KMT2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| WO-2018204764-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION (US) | 2018-11-08 | — | — | WO | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| EP-1351982-B1 | X RAY CRYSTAL STRUCTURES AT 5.5 A RESOLUTION OF FUNCTIONAL COMPLEXES OF THE BACTERIAL RIBOSOME CONTAINING TRANSFER RNA AND MODEL MESSENGER RNAS | UNIV CALIFORNIA (US) | 2008-02-13 | — | — | EP | disclosed |